Safety and Efficacy Study of Interferon to Treat Patients Hospitalized for Influenza

Summary

A Pilot Study to Evaluate the Safety and Efficacy of interferon-Alfacon1 (INFERGEN) in the treatment of patients hospitalized with Influenza-like illness caused by a novel swine origin Influenza virus and other circulating Influenza Viruses. The use of Interferon-alfacon1 as a co-treatment along with the standard of care antiviral is hypothesized to be safe. Clinical improvement of patients is hypothesized to be quicker.

Timeline

Start

2010-11

Primary completion

2011-11

Completion

2011-11

Drugs

Indications